Australia markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
137.92+0.09 (+0.07%)
At close: 04:00PM EDT
138.50 +0.58 (+0.42%)
After hours: 06:10PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18171919
Avg. Estimate11.194.86.29
Low estimate0.210.893.844.58
High estimate1.771.675.728.51
Year ago EPS-0.790.952.474.8
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts25232727
Avg. Estimate514.49M546.04M2.21B2.57B
Low estimate493M528M2.14B2.26B
High estimate546M591.3M2.32B3.78B
Year ago sales409.26M447.31M1.89B2.21B
Sales growth (year/est)25.70%22.10%17.30%16.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.130.780.971.14
Actual EPS-0.790.950.821.44
Difference-0.920.17-0.150.3
Surprise %-707.70%21.80%-15.50%26.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate11.194.86.29
7 days ago11.194.86.29
30 days ago11.194.796.3
60 days ago1.051.154.696.39
90 days ago1.071.24.656.32
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNBIXIndustrySector(s)S&P 500
Current qtr.226.60%N/AN/AN/A
Next qtr.25.30%N/AN/AN/A
Current year94.30%N/AN/AN/A
Next year31.00%N/AN/AN/A
Next 5 years (per annum)18.00%N/AN/AN/A
Past 5 years (per annum)22.55%N/AN/AN/A